✦ LIBER ✦

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

✍ Scribed by Isabel Lastres-Becker; Francisco Molina-Holgado; José A. Ramos; Raphael Mechoulam; Javier Fernández-Ruiz

Book ID: 116761734
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 295 KB
Volume: 19
Category: Article
ISSN: 0969-9961
DOI: 10.1016/j.nbd.2004.11.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nrf2 activators provide neuroprotection

Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures

✍ Aubrey Siebert; Vandan Desai; Krish Chandrasekaran; Gary Fiskum; M. Samir Jafri 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

## Abstract Oxidative stress and inflammation appear to play a critical role in the progression of Parkinson's disease. As a result, there has been growing interest in antioxidant pathways and how these pathways might be exploited to slow the progressive loss of dopamine neurons. One such pathway t

In vitro and in vivo neuroprotection by

In vitro and in vivo neuroprotection by γ-glutamylcysteine ethyl ester against MPTP: Relevance to the role of glutathione in Parkinson's disease

✍ Shankar J. Chinta; Subramanian Rajagopalan; D. Allan Butterfield; Julie K. Ander 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 191 KB

SF-6 attenuates 6-hydroxydopamine-induce

SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: An in vitro and in vivo investigation in experimental models of Parkinson's disease

✍ Spandana Rajendra Kopalli; Sushruta Koppula; Ki Young Shin; Su-Jin Noh; Qinghao 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 924 KB

In vitro and in vivo studies investigati

In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson’s and Alzheimer’s diseases

✍ W. Linert; M.H. Bridge; M. Huber; K.B. Bjugstad; S. Grossman; G.W. Arendash 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 394 KB

116. A novel moderate-affinity metal bin

116. A novel moderate-affinity metal binding ligand confers neuroprotection against 6-hydroxydopamine mediated chronic cell death and improves rotational behavior in a mouse model of parkinson’s disease

✍ Simon Wilkins; Karoline Deleva; Mikhalina Cortes; Mila Nurjono; Irene Volitakis; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Neuroprotective effects of the novel D3/

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

✍ Jeffrey N Joyce; Steve Presgraves; Lynn Renish; Sabinne Borwege; Tracy Osredkar; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 870 KB